Global Cetirizine Hydrochloride Market Growth 2025-2031

The global Cetirizine Hydrochloride market size is predicted to grow from US$ 849 million in 2025 to US$ 943 million in 2031; it is expected to grow at a CAGR of 1.8% from 2025 to 2031.

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

The major players in the industry are J & J, UCB Pharma, GSK, etc. The proportion of revenue in 2019 is 29.00%, 25.87%, 11.39%. North America has the highest market share by region, accounting for more than 33.8 percent of revenue.

LP Information, Inc. (LPI) ' newest research report, the “Cetirizine Hydrochloride Industry Forecast” looks at past sales and reviews total world Cetirizine Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Cetirizine Hydrochloride sales for 2025 through 2031. With Cetirizine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cetirizine Hydrochloride industry.

This Insight Report provides a comprehensive analysis of the global Cetirizine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cetirizine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cetirizine Hydrochloride market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cetirizine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cetirizine Hydrochloride.

This report presents a comprehensive overview, market shares, and growth opportunities of Cetirizine Hydrochloride market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tablet
Capsule
Solution

Segmentation by Application:
Hospital
Drug Store
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
J & J
UCB Pharma
GSK
Teva
HUAPONT Pharm
Sun Pharma
Hunan Jiudian Pharm
Lunan Pharma
Mylan
Apotex
Jubilant Life Sciences
HAILISHENG

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cetirizine Hydrochloride market?

What factors are driving Cetirizine Hydrochloride market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cetirizine Hydrochloride market opportunities vary by end market size?

How does Cetirizine Hydrochloride break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.